ADVANTAGES OF SHORT-TERM AND PROLONGED COURSES OF PREOPERATIVE RADIATION THERAPY FOR RECTAL CANCER
##article.numberofdownloads## 111
##article.numberofviews## 174
PDF (Русский)

Keywords

RECTAL CANCER
PREOPERATIVE RADIATION THERAPY
PROLONGED COURSE
SHORT-TERM COURSE

How to Cite

Kit, O., Gevorkyan, Y., Gusareva, M., Rozenko, L., Soldatkina, N., Kharagezov, D., & Beletskiy, G. (2018). ADVANTAGES OF SHORT-TERM AND PROLONGED COURSES OF PREOPERATIVE RADIATION THERAPY FOR RECTAL CANCER. Voprosy Onkologii, 64(1), 110–115. https://doi.org/10.37469/0507-3758-2018-64-1-110-115

Abstract

Results of preoperative radiation therapy for 119 patients with resectable rectal T3-4N0-1M0 cancer were analyzed. 52 patients received a short-term course of the large-fraction radiation therapy and 67 patients received a prolonged course of chemoradiation therapy. The results demonstrated that the prolonged course reduced clinical signs of the disease twice as much as the short course, it reduced the tumor size and increased the distance to the anorectal line (p<0.05) which increased the number of sphincter-preserving surgeries for cancer of the rectal lower ampulla. 1-year disease-free survival after the prolonged course was 20% higher in comparison with the short-term course (Long-Rank Test=0.045). 3-year disease-free and overall survival was similar in both groups of patients. The advantages of short and prolonged courses of preoperative radiation therapy for rectal cancer should be considered when planning the treatment.
https://doi.org/10.37469/0507-3758-2018-64-1-110-115
##article.numberofdownloads## 111
##article.numberofviews## 174
PDF (Русский)

References

Кит О.И. Проблема колоректального рака в начале XXI века: достижения и перспективы/Российский журнал Гастроэнтерологии, Гепатологии, Колопроктологии. -2013. -№ 3 (23). -С. 65-71.

Кит О.И., Геворкян Ю.А., Солдаткина Н.В. и др. Клинико-морфологические эффекты предоперационной лучевой терапии крупным фракционированием дозы при раке прямой кишки//Тюменский медицинский журнал. -2016. -Т 18. -№ 2. -С. 39-45.

Peeters K.C., Marijnen C.A., NagtegaalIDetal. The TME trial after a median follow-up jf 6 years:increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma//Ann. Surg. -2007. -Vol. 246. -P. 693.

Ferrari L., Fichera A. Neoadjuvantchemoradiation therapy and pathological complete response in rectal cancer//Gastroenterol Rep. (Oxf). -2015. -Vol. 3. -№ 4. -Р. 277-288.

Stockholm Rectal Cancer Study Group: Preoperative short-term radiotherapy in operable rectal carcinoma: a prospective randomized study//Cancer. -1990. -Vol. 66. -P 49-55.

Swedish Rectal Cancer Trial: improved survival with preoperative radiotherapy in resectable rectal cancer//N. Engl. J. Med. -1997. -Vol. 336. -P 980-987.

Taylor F.G. Preoperative magnetic resonance imaging of circumferential resetion margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study//J. Clin. Oncol. -2014. -Vol. 32. -№ 1. -P 34-43.

McCoy M.J. Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumor regression?//ANZ.J. Surg. -2015.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2018